不妊治療市場

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2021年10月

不妊治療市場：製品（機器、メディア、アクセサリー）、手順（ART（IVF、ICSI、代理）、授精、腹腔鏡検査、子宮鏡検査、患者タイプ（女性、男性）、エンドユーザー（不妊治療クリニック、病院、研究）- 2026年までの世界予測

Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) – Global Forecast to 2026

–

–

The global infertility treatment market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1 % during the forecast period. Factors such as decline in the fertility rates worldwide, increase adoption of different infertility procedures, rising number of fertility clinics worldwide, rise in public & private investments and presence of advanced infertility treatment products in the market are anticipated to boost the growth of the market.

The recent COVID-19 global pandemic has also impacted the infertility treatment market. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete. In India, 30 lakh people seek infertility treatment every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who were opting for IVF treatment before the pandemic.
“The equipment to capture the largest share in infertility treatment market, by products during the forecast period.”
The equipment segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the technological advancements and presence of well-established players with strong product portfolio. Along with this growing focus of players towards base expansion through adopting various strategies such as new equipment launch, showcase across the globe is likely to contribute towards the growth of the segment.
“The assisted reproductive technology (ART) to capture the largest market share of infertility treatment market, by the procedure in 2021.”
The assisted reproductive technology segment captured the largest share of the infertility treatment market procedures during the forecast period. The growing awareness of the presence of ART, rise in success rate of this procedure and growing worldwide acceptance of ART is likely to boost the growth of the segment.
“The female infertility treatment segment commanded for the largest share of the infertility treatment market, by patient type, in 2021”
The decreasing rates of fertility among females, growing availability of various fertility treatment options, and the increasing number of fertility centers across the globe are driving the growth of the female infertility treatment market.

“The fertility centers segment accounted for the largest share of the infertility treatment market, by end user, in 2021”
The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, and the increasing popularity of IVF & ICSI treatment globally are some of the factors likely to contribute towards the rapid growth of the segment.

“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The infertility treatment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in the awareness of availability of infertility treatment procedures, growing fertility centers in the region, rising healthcare expenditures, increasing patient population, growing medical tourism, improving healthcare expenditure on infertility treatment, and initiatives by the government to increase the accessibility of the infertility treatment in the emerging nations.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 26%, D-level: 30%, and Others: 44%
• By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%

The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US).

Research Coverage
This report studies the global infertility treatment market based on the product, procedure, patient type, end users, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global infertility treatment market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

目次

1INTRODUCTION31
1.1OBJECTIVES OF THE STUDY31
1.2MARKET DEFINITION31
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY32
1.3MARKET SCOPE33
1.3.1MARKETS COVERED33
1.3.2YEARS CONSIDERED FOR THE STUDY34
1.4CURRENCY USED FOR THE STUDY34
1.5MAJOR MARKET STAKEHOLDERS34
1.6SUMMARY OF CHANGES35
2RESEARCH METHODOLOGY36
2.1RESEARCH DATA36
FIGURE 1RESEARCH DESIGN36
2.1.1SECONDARY DATA37
2.1.1.1Secondary sources38
2.1.2PRIMARY DATA38
FIGURE 2BREAKDOWN OF PRIMARIES: INFERTILITY TREATMENT MARKET39
2.2MARKET ESTIMATION METHODOLOGY39
FIGURE 3RESEARCH METHODOLOGY: HYPOTHESIS BUILDING40
2.2.1REVENUE MAPPING-BASED MARKET ESTIMATION40
2.2.2USAGE-BASED MARKET ESTIMATION41
FIGURE 4MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
BASED ON PRODUCT UTILIZATION METHODOLOGY41
FIGURE 5MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
BASED ON REVENUE MAPPING METHODOLOGY42
2.2.3PRIMARY RESEARCH VALIDATION42
2.3DATA TRIANGULATION43
FIGURE 6DATA TRIANGULATION METHODOLOGY43
2.4RESEARCH ASSUMPTIONS44
2.5RESEARCH LIMITATIONS44
3EXECUTIVE SUMMARY45
FIGURE 7INFERTILITY TREATMENT MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION)45
FIGURE 8INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION)46
FIGURE 9INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2021 VS. 2026 (USD MILLION)47
FIGURE 10INFERTILITY TREATMENT MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)48
FIGURE 11GEOGRAPHICAL SNAPSHOT OF THE INFERTILITY TREATMENT MARKET49
4PREMIUM INSIGHTS50
4.1INFERTILITY TREATMENT MARKET OVERVIEW50
FIGURE 12DECLINING FERTILITY RATE AND RISING NUMBER OF FERTILITY CLINICS WORLDWIDE TO DRIVE MARKET GROWTH50
4.2INFERTILITY TREATMENT MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)51
FIGURE 13MEDIA & CONSUMABLES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE INFERTILITY TREATMENT MARKET DURING THE FORECAST PERIOD51
4.3INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)52
FIGURE 14ASSISTED REPRODUCTIVE TECHNOLOGY IS THE LARGEST PROCEDURE SEGMENT OF THE INFERTILITY TREATMENT MARKET52
4.4INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION)53
FIGURE 15MALE INFERTILITY TREATMENT SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD53
4.5INFERTILITY TREATMENT MARKET SHARE, BY END USER, 202154
FIGURE 16FERTILITY CENTERS ARE THE LARGEST END USERS OF INFERTILITY TREATMENT PRODUCTS54
4.6ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT AND COUNTRY (2021)55
FIGURE 17EQUIPMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE APAC INFERTILITY TREATMENT MARKET IN 202155
FIGURE 18APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021–2026)56
5MARKET OVERVIEW57
5.1INTRODUCTION57
5.2MARKET DYNAMICS57
FIGURE 19INFERTILITY TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES57
5.2.1DRIVERS58
5.2.1.1Declining fertility rate58
FIGURE 20DECLINING GLOBAL FERTILITY RATE, BY REGION, 1990 VS. 2019 VS. 203058
FIGURE 21RISING OBESITY RATES (PERCENTAGE OF THE US POPULATION):
2010 VS. 203059
5.2.1.2Rising number of fertility clinics worldwide60
5.2.1.3Technological advancements60
5.2.1.3.1Advancements in infertility treatment devices60
5.2.1.3.2Increasing use of time-lapse technology worldwide61
5.2.1.4Increasing public-private investments, funds, and grants61
5.2.2RESTRAINTS62
5.2.2.1High costs associated with assisted reproductive technology in developed markets62
TABLE 1INFERTILITY TREATMENT COSTS62
5.2.2.2Unsupportive government regulations63
 
5.2.3OPPORTUNITIES64
5.2.3.1Growth opportunities in emerging markets64
5.2.3.1.1Improving healthcare infrastructure64
5.2.3.2Increasing medical tourism due to low treatment costs64
5.2.3.3Use of fertility treatment options by single parents and same-sex couples65
5.2.4CHALLENGES65
5.2.4.1Concerns related to ART procedures65
5.2.4.2Reduced efficacy among older women66
5.3REGULATORY LANDSCAPE66
5.3.1NORTH AMERICA66
5.3.1.1US66
5.3.1.2Canada67
5.3.2EUROPE67
5.3.3ASIA PACIFIC67
5.3.3.1India67
5.3.3.2Japan67
TABLE 2JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA68
5.4COVID-19 IMPACT ON THE INFERTILITY TREATMENT MARKET68
5.5VALUE CHAIN ANALYSIS69
FIGURE 22VALUE CHAIN OF THE INFERTILITY TREATMENT MARKET69
5.6PRICING TREND ANALYSIS70
TABLE 3AVERAGE PRICE OF INFERTILITY TREATMENT EQUIPMENT AND MEDIA,
BY COUNTRY, 2020 (USD)70
5.7PORTER’S FIVE FORCES ANALYSIS71
TABLE 4INFERTILITY TREATMENT MARKET: PORTER’S FIVE FORCES ANALYSIS71
5.7.1THREAT OF NEW ENTRANTS71
FIGURE 23THREAT OF NEW ENTRANTS72
5.7.2THREAT OF SUBSTITUTES72
FIGURE 24THREAT OF SUBSTITUTES72
5.7.3BARGAINING POWER OF SUPPLIERS73
FIGURE 25BARGAINING POWER OF SUPPLIERS73
5.7.4BARGAINING POWER OF BUYERS73
FIGURE 26BARGAINING POWER OF BUYERS73
5.7.5INTENSITY OF COMPETITIVE RIVALRY74
FIGURE 27INTENSITY OF COMPETITIVE RIVALRY74
5.8ECOSYSTEM COVERAGE74
 
6INFERTILITY TREATMENT MARKET, BY PRODUCT75
6.1INTRODUCTION76
TABLE 5INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION)76
6.1.1EQUIPMENT76
TABLE 6INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)77
TABLE 7INFERTILITY TREATMENT EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION)77
6.2MICROSCOPES78
6.2.1TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF MICROSCOPY HAS RESULTED IN THE GROWING ADOPTION OF MICROSCOPES78
TABLE 8MICROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)78
TABLE 9MICROSCOPES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)79
TABLE 10MICROSCOPES MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)79
TABLE 11MICROSCOPES MARKET, BY END USER, 2019–2026 (USD MILLION)80
6.2.2IMAGING SYSTEMS80
6.2.2.1Advantages offered by imaging systems in the field of infertility treatment are driving their adoption80
TABLE 12IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)81
TABLE 13IMAGING SYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)81
TABLE 14IMAGING SYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)82
TABLE 15IMAGING SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)82
6.2.3SPERM ANALYZER SYSTEMS82
6.2.3.1Sperm analyzer systems have a wide range of applications in fertility screening82
TABLE 16SPERM ANALYZER SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION)83
TABLE 17SPERM ANALYZER SYSTEMS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)83
TABLE 18SPERM ANALYZER SYSTEMS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)84
TABLE 19SPERM ANALYZER SYSTEMS MARKET, BY END USER,
2019–2026 (USD MILLION)84
6.2.4OVUM ASPIRATION PUMPS84
6.2.4.1Ovum aspiration pumps are widely used to retrieve and protect oocytes84
TABLE 20OVUM ASPIRATION PUMPS MARKET, BY REGION,
2019–2026 (USD MILLION)85
TABLE 21OVUM ASPIRATION PUMPS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)85
TABLE 22OVUM ASPIRATION PUMPS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)86
TABLE 23OVUM ASPIRATION PUMPS MARKET, BY END USER,
2019–2026 (USD MILLION)86
6.2.5MICROMANIPULATOR SYSTEMS86
6.2.5.1Micromanipulator systems are used in cases pertaining to poor sperm quality/mobility86
TABLE 24MICROMANIPULATOR SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION)87
TABLE 25MICROMANIPULATOR SYSTEMS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)88
TABLE 26MICROMANIPULATOR SYSTEMS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)88
TABLE 27MICROMANIPULATOR SYSTEMS MARKET, BY END USER,
2019–2026 (USD MILLION)89
6.2.6INCUBATORS89
6.2.6.1Incubators play a vital role in embryo development and improved clinical outcomes89
TABLE 28INCUBATORS MARKET, BY REGION, 2019–2026 (USD MILLION)90
TABLE 29INCUBATORS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)90
TABLE 30INCUBATORS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)91
TABLE 31INCUBATORS MARKET, BY END USER, 2019–2026 (USD MILLION)91
6.2.7GAS ANALYZERS91
6.2.7.1Gas analyzers contain multiple ports enabling analysis of sequential gas samples91
TABLE 32GAS ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)92
TABLE 33GAS ANALYZERS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)92
TABLE 34GAS ANALYZERS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)93
TABLE 35GAS ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)93
6.2.8LASER SYSTEMS93
6.2.8.1Common applications of laser systems include the treatment of stress urinary incontinence and vaginal tightening93
TABLE 36LASER SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)94
TABLE 37LASER SYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)94
TABLE 38LASER SYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)95
TABLE 39LASER SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)95
6.2.9CRYOSYSTEMS95
6.2.9.1Demand for cryosystems is on the rise as women are seeking to extend their childbearing years95
TABLE 40CRYOSYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)96
TABLE 41CRYOSYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)96
TABLE 42CRYOSYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)97
TABLE 43CRYOSYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)97
6.2.10SPERM SEPARATION DEVICES98
6.2.10.1Introduction of advanced sperm separation devices to boost their adoption98
TABLE 44SPERM SEPARATION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION)98
TABLE 45SPERM SEPARATION DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)99
TABLE 46SPERM SEPARATION DEVICES MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)99
TABLE 47SPERM SEPARATION DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)100
6.3MEDIA & CONSUMABLES100
6.3.1EASY AVAILABILITY OF CULTURE MEDIA TO SUPPORT MARKET GROWTH100
TABLE 48INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)101
TABLE 49INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)101
TABLE 50INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)102
TABLE 51INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY END USER, 2019–2026 (USD MILLION)102
6.4ACCESSORIES103
6.4.1ANTI-VIBRATION TABLES ARE COMMONLY USED FOR IVF TREATMENTS TO PROVIDE A SMOOTH WORKSPACE DURING PROCEDURES103
TABLE 52INFERTILITY TREATMENT ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION)103
TABLE 53INFERTILITY TREATMENT ACCESSORIES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)104
TABLE 54INFERTILITY TREATMENT ACCESSORIES MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)104
TABLE 55INFERTILITY TREATMENT ACCESSORIES MARKET, BY END USER,
2019–2026 (USD MILLION)105
7INFERTILITY TREATMENT MARKET, BY PROCEDURE106
7.1INTRODUCTION107
TABLE 56INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)107
7.2ASSISTED REPRODUCTIVE TECHNOLOGY107
TABLE 57ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION)108
TABLE 58ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION)108
7.2.1IN VITRO FERTILIZATION108
FIGURE 28UK: IVF BIRTH RATES, 2010–2019109
TABLE 59IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION)109
TABLE 60IN VITRO FERTILIZATION MARKET, BY REGION, 2019–2026 (USD MILLION)110
7.2.1.1Intracytoplasmic morphologically selected sperm injection110
7.2.1.1.1IMSI is highly recommended in patients with a low sperm count and recurrent implantation failure110
TABLE 61INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION MARKET, BY REGION, 2019–2026 (USD MILLION)111
7.2.1.2Gamete donation111
7.2.1.2.1Increasing number of women registering as egg donors is a key factor aiding market growth111
TABLE 62GAMETE DONATION MARKET, BY REGION, 2019–2026 (USD MILLION)112
7.2.2INTRACYTOPLASMIC SPERM INJECTION112
7.2.2.1ICSI is a specialized form of IVF involving fertilization used commonly in male infertility treatment procedures112
TABLE 63INTRACYTOPLASMIC SPERM INJECTION MARKET, BY REGION,
2019–2026 (USD MILLION)113
7.2.3SURROGACY113
7.2.3.1High success rates guaranteed and achieved with the help of surrogacy are driving market growth113
TABLE 64SURROGACY MARKET, BY REGION, 2019–2026 (USD MILLION)114
7.3ARTIFICIAL INSEMINATION114
TABLE 65ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019–2026 (USD MILLION)115
TABLE 66ARTIFICIAL INSEMINATION MARKET, BY REGION, 2019–2026 (USD MILLION)115
7.3.1INTRAUTERINE INSEMINATION116
7.3.1.1Limited risk of complications during pregnancy and high success rate are driving the market for IUI procedures116
TABLE 67INTRAUTERINE INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION)116
7.3.2INTRACERVICAL INSEMINATION117
7.3.2.1Low cost of this procedure as compared to other AI procedures to support market growth117
TABLE 68INTRACERVICAL INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION)117
7.3.3INTRATUBAL INSEMINATION117
7.3.3.1High cost and uncertain success rate of this procedure to restrain the market growth117
TABLE 69INTRATUBAL INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION)118
7.4FERTILITY SURGERIES118
TABLE 70FERTILITY SURGERIES MARKET, BY TYPE, 2019–2026 (USD MILLION)118
TABLE 71FERTILITY SURGERIES MARKET, BY REGION, 2019–2026 (USD MILLION)119
7.4.1LAPAROSCOPY119
7.4.1.1Laparoscopy allows for the biopsy of suspect growths and cysts that hamper fertility119
TABLE 72LAPAROSCOPY MARKET, BY REGION, 2019–2026 (USD MILLION)120
7.4.2HYSTEROSCOPY120
7.4.2.1Growing demand for minimally invasive procedures is driving the adoption of hysteroscopy infertility treatment surgeries globally120
TABLE 73HYSTEROSCOPY MARKET, BY REGION, 2019–2026 (USD MILLION)121
7.4.3MYOMECTOMY121
7.4.3.1Advantages of myomectomy in alleviating problems caused due to fibroids while preserving future fertility to drive the demand for this surgery121
TABLE 74MYOMECTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)122
7.4.4LAPAROTOMY122
7.4.4.1Laparotomy is used in common infertility surgeries that require large exposure to the reproductive system122
TABLE 75LAPAROTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)122
7.4.5TUBAL LIGATION REVERSAL123
7.4.5.1Tubal ligation reversal is performed in women who still have a large portion of healthy fallopian tube remaining123
TABLE 76TUBAL LIGATION REVERSAL MARKET, BY REGION,
2019–2026 (USD MILLION)123
7.4.6VARICOCELECTOMY124
7.4.6.1Varicocelectomy results in a high chance of improved fertility with reduced complications124
TABLE 77VARICOCELECTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)124
7.4.7MICROSURGICAL RECONSTRUCTION124
TABLE 78MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE,
2019–2026 (USD MILLION)125
TABLE 79MICROSURGICAL RECONSTRUCTION MARKET, BY REGION,
2019–2026 (USD MILLION)125
7.4.7.1Vasovasostomy125
7.4.7.1.1Vasovasostomy is a reversal surgery commonly used in the treatment of infertility in men125
TABLE 80VASOVASOSTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)126
7.4.7.2Vasoepididymostomy126
7.4.7.2.1Vasoepididymostomy provides a higher pregnancy rate than IVF with ICSI126
TABLE 81VASOEPIDIDYMOSTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)127
7.5OTHER INFERTILITY TREATMENT PROCEDURES127
TABLE 82OTHER INFERTILITY TREATMENT PROCEDURES MARKET, BY REGION,
2019–2026 (USD MILLION)128
8INFERTILITY TREATMENT MARKET, BY PATIENT TYPE129
8.1INTRODUCTION130
TABLE 83INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)130
8.2FEMALE INFERTILITY TREATMENT130
8.2.1INCREASING FEMALE INFERTILITY RATES TO DRIVE THE GROWTH OF THE FEMALE INFERTILITY TREATMENT MARKET130
FIGURE 29US: IVF SUCCESS RATES BY AGE FOR ALL IVF CYCLES, 2019131
TABLE 84FEMALE INFERTILITY TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION)131
8.3MALE INFERTILITY TREATMENT132
8.3.1GROWING ADOPTION OF MALE INFERTILITY TREATMENT PROCEDURES TO DRIVE MARKET GROWTH132
TABLE 85MALE INFERTILITY TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION)132
 
9INFERTILITY TREATMENT MARKET, BY END USER133
9.1INTRODUCTION134
TABLE 86INFERTILITY TREATMENT MARKET, BY END USER, 2019–2026 (USD MILLION)134
9.2FERTILITY CENTERS134
9.2.1GROWING NUMBER OF INFERTILITY TREATMENT CENTERS WORLDWIDE TO DRIVE MARKET GROWTH134
TABLE 87INFERTILITY TREATMENT MARKET FOR FERTILITY CENTERS, BY REGION, 2019–2026 (USD MILLION)135
9.3HOSPITALS & SURGICAL CLINICS135
9.3.1GOVERNMENT INITIATIVES TO INCREASE HOSPITALS EQUIPPED TO PERFORM INFERTILITY TREATMENT PROCEDURES IS SUPPORTING MARKET GROWTH135
TABLE 88INFERTILITY TREATMENT MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2019–2026 (USD MILLION)136
9.4CRYOBANKS136
9.4.1INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS FOR INFERTILITY TREATMENT TO DRIVE MARKET GROWTH136
TABLE 89INFERTILITY TREATMENT MARKET FOR CRYOBANKS, BY REGION,
2019–2026 (USD MILLION)137
9.5RESEARCH INSTITUTES137
9.5.1GROWING NEED FOR IMPROVING THE CLINICAL EFFICACY OF VARIOUS INFERTILITY TREATMENT OPTIONS TO DRIVE MARKET GROWTH137
TABLE 90INFERTILITY TREATMENT MARKET FOR RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)138
10INFERTILITY TREATMENT MARKET, BY REGION139
10.1INTRODUCTION140
TABLE 91INFERTILITY TREATMENT MARKET, BY REGION, 2019–2026 (USD MILLION)140
10.2ASIA PACIFIC140
TABLE 93ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)142
TABLE 94ASIA PACIFIC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)142
TABLE 95ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)143
TABLE 96ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)143
TABLE 97ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION)144
TABLE 98ASIA PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION)144
TABLE 99ASIA PACIFIC: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)145
TABLE 100ASIA PACIFIC: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION)145
TABLE 101ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)146
TABLE 102ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION)146
10.2.1CHINA147
10.2.1.1Declining birth rate in China to drive the demand for infertility treatment procedures in the country147
TABLE 103CHINA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)147
TABLE 104CHINA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)148
10.2.2JAPAN148
10.2.2.1Growing awareness has served to boost the adoption of IVF procedures in Japan148
TABLE 105JAPAN: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)149
TABLE 106JAPAN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)150
10.2.3INDIA150
10.2.3.1Rising medical tourism to offer high-growth opportunities for players in the Indian infertility treatment market150
TABLE 107INDIA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)151
TABLE 108INDIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)152
10.2.4AUSTRALIA152
10.2.4.1Initiatives by the Australian government to support market growth152
TABLE 109AUSTRALIA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)153
TABLE 110AUSTRALIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)153
10.2.5SOUTH KOREA154
10.2.5.1Supportive government initiatives will positively impact market growth154
TABLE 111SOUTH KOREA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)154
TABLE 112SOUTH KOREA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)155
10.2.6REST OF ASIA PACIFIC155
TABLE 113ROAPAC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)156
TABLE 114ROAPAC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)156
10.3EUROPE157
TABLE 115EUROPE: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)157
TABLE 116EUROPE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)158
TABLE 117EUROPE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)158
TABLE 118EUROPE: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)159
TABLE 119EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION)159
TABLE 120EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION)160
TABLE 121EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION)160
TABLE 122EUROPE: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)161
TABLE 123EUROPE: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE,
2019–2026 (USD MILLION)161
TABLE 124EUROPE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)162
TABLE 125EUROPE: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION)162
10.3.1GERMANY162
10.3.1.1Favorable funding scenario for IVF treatments in Germany to drive market growth162
TABLE 126GERMANY: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)163
TABLE 127GERMANY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)164
10.3.2UK164
10.3.2.1Supportive regulatory framework in the UK to drive market growth164
FIGURE 31UK: NUMBER OF IVF CYCLES BY EGG AND SPERM SOURCE, 2010-2019165
TABLE 128UK: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)165
TABLE 129UK: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)166
10.3.3FRANCE166
10.3.3.1Rising healthcare spending in France to drive market growth166
TABLE 130FRANCE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)167
TABLE 131FRANCE: INFERTILITY TREATMENT EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION)168
10.3.4ITALY168
10.3.4.1Decreasing fertility rates to drive the demand for fertility testing treatment procedures in Italy168
TABLE 132ITALY: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)169
TABLE 133ITALY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)169
10.3.5SPAIN170
10.3.5.1Spain is an established destination for IVF tourism170
TABLE 134SPAIN: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)170
TABLE 135SPAIN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)171
10.3.6REST OF EUROPE171
TABLE 136ROE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)172
TABLE 137ROE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)172
10.4NORTH AMERICA173
TABLE 138NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)173
TABLE 139NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)173
TABLE 140NORTH AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)174
TABLE 141NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)174
TABLE 142NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)175
TABLE 143NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION)175
TABLE 144NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION)176
TABLE 145NORTH AMERICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)176
TABLE 146NORTH AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION)177
TABLE 147NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)177
TABLE 148NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION)178
10.4.1US178
10.4.1.1The US dominates the infertility treatment market in North America178
TABLE 149US: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)179
TABLE 150US: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)180
10.4.2CANADA180
10.4.2.1High cost of infertility treatment in the country to restrain the market growth180
TABLE 151CANADA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)181
TABLE 152CANADA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)181
10.5LATIN AMERICA182
TABLE 153LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)182
TABLE 154LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)182
TABLE 155LATIN AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)183
TABLE 156LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)183
TABLE 157LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)184
TABLE 158LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION)184
TABLE 159LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION)185
TABLE 160LATIN AMERICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)185
TABLE 161LATIN AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION)186
TABLE 162LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)186
TABLE 163LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION)187
10.5.1BRAZIL187
10.5.1.1Brazil holds the largest share of the Latin American infertility treatment market187
TABLE 164BRAZIL: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)187
TABLE 165BRAZIL: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)188
10.5.2MEXICO188
10.5.2.1Growth in medical tourism is a key factor driving market growth188
TABLE 166MEXICO: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)189
TABLE 167MEXICO: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)189
10.5.3REST OF LATIN AMERICA190
TABLE 168ROLATAM: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)190
TABLE 169ROLATAM: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)191
10.6MIDDLE EAST & AFRICA191
10.6.1RISING INCIDENCE OF INFERTILITY TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD191
TABLE 170MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION)192
TABLE 171MIDDLE EAST & AFRICA: INFERTILITY TREATMENT EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION)193
TABLE 172MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)193
TABLE 173MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)194
TABLE 174MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION)194
TABLE 175MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019–2026 (USD MILLION)195
TABLE 176MIDDLE EAST & AFRICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)195
TABLE 177MIDDLE EAST & AFRICA: MICROSURGICAL RECONSTRUCTION MARKET,
BY TYPE, 2019–2026 (USD MILLION)196
TABLE 178MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)196
TABLE 179MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY END USER, 2019–2026 (USD MILLION)197
11COMPETITIVE LANDSCAPE198
11.1OVERVIEW198
11.2KEY PLAYER STRATEGIES198
11.3REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS199
FIGURE 32REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET199
11.4MARKET SHARE ANALYSIS (2020)199
TABLE 180INFERTILITY TREATMENT MARKET: DEGREE OF COMPETITION199
11.5COMPETITIVE LEADERSHIP MAPPING201
11.5.1STARS201
11.5.2PERVASIVE PLAYERS201
11.5.3EMERGING LEADERS201
11.5.4PARTICIPANTS202
FIGURE 33INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP
MAPPING, 2020202
11.6COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)203
11.6.1PROGRESSIVE COMPANIES203
11.6.2STARTING BLOCKS203
11.6.3RESPONSIVE COMPANIES203
11.6.4DYNAMIC COMPANIES203
FIGURE 34INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2020204
11.7FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET205
11.7.1PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET205
TABLE 181PRODUCT FOOTPRINT OF COMPANIES206
11.8COMPETITIVE SCENARIO208
11.8.1INFERTILITY TREATMENT MARKET: PRODUCT LAUNCHES AND
REGULATORY APPROVALS208
TABLE 183KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS, JANUARY
2018–SEPTEMBER 2021208
11.8.2INFERTILITY TREATMENT MARKET: DEALS208
TABLE 184KEY DEALS, JANUARY 2018–SEPTEMBER 2021208
11.8.3INFERTILITY TREATMENT MARKET: OTHER DEVELOPMENTS209
TABLE 185OTHER KEY DEVELOPMENTS, JANUARY 2018–SEPTEMBER 2021209
12COMPANY PROFILES210
12.1MAJOR PLAYERS210
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1THE COOPER COMPANIES INC.210
TABLE 186THE COOPER COMPANIES INC.: BUSINESS OVERVIEW210
FIGURE 35THE COOPER COMPANIES INC.: COMPANY SNAPSHOT (2020)211
TABLE 187THE COOPER COMPANIES, INC.: PRODUCT OFFERINGS212
12.1.2COOK GROUP214
TABLE 188COOK GROUP: BUSINESS OVERVIEW214
TABLE 189COOK GROUP: PRODUCT OFFERINGS214
12.1.3VITROLIFE216
TABLE 190VITROLIFE: BUSINESS OVERVIEW216
FIGURE 36VITROLIFE: COMPANY SNAPSHOT (2020)217
TABLE 191VITROLIFE: PRODUCT OFFERINGS218
12.1.4THERMO FISHER SCIENTIFIC220
TABLE 192THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW220
FIGURE 37THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)221
TABLE 193THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS222
12.1.5HAMILTON THORNE LTD.224
TABLE 194HAMILTON THORNE LTD.: BUSINESS OVERVIEW224
FIGURE 38HAMILTON THORNE LTD.: COMPANY SNAPSHOT (2020)224
TABLE 195HAMILTON THORNE LTD.: PRODUCT OFFERINGS225
12.1.6ESCO MICRO PTE. LTD.227
TABLE 196ESCO MICRO PTE. LTD.: BUSINESS OVERVIEW227
TABLE 197ESCO MICRO PTE. LTD.: PRODUCT OFFERINGS227
12.1.7GENEA LIMITED229
TABLE 198GENEA LIMITED: BUSINESS OVERVIEW229
TABLE 199GENEA LIMITED: PRODUCT OFFERINGS229
12.1.8IVFTECH APS231
TABLE 200IVFTECH APS: BUSINESS OVERVIEW231
TABLE 201IVFTECH APS: PRODUCT OFFERINGS231
12.1.9FUJIFILM IRVINE SCIENTIFIC232
TABLE 202FUJIFILM IRVINE SCIENTIFIC: BUSINESS OVERVIEW232
FIGURE 39FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)232
TABLE 203FUJIFILM IRVINE SCIENTIFIC: PRODUCT OFFERINGS233
12.1.10THE BAKER COMPANY, INC.235
TABLE 204THE BAKER COMPANY, INC.: BUSINESS OVERVIEW235
TABLE 205THE BAKER COMPANY, INC.: PRODUCT OFFERINGS235
12.1.11KITAZATO CORPORATION236
TABLE 206KITAZATO CORPORATION: BUSINESS OVERVIEW236
TABLE 207KITAZATO CORPORATION: PRODUCT OFFERINGS236
12.1.12ROCKET MEDICAL PLC238
TABLE 208ROCKET MEDICAL PLC: BUSINESS OVERVIEW238
TABLE 209ROCKET MEDICAL PLC: PRODUCT OFFERINGS238
12.1.13IHMEDICAL A/S239
TABLE 210IHMEDICAL A/S: BUSINESS OVERVIEW239
TABLE 211IHMEDICAL A/S: PRODUCT OFFERINGS239
12.1.14ZEISS GROUP240
TABLE 212ZEISS GROUP: BUSINESS OVERVIEW240
FIGURE 40ZEISS GROUP: COMPANY SNAPSHOT (2020)241
TABLE 213ZEISS GROUP: PRODUCT OFFERINGS241
12.1.15MEDGYN PRODUCTS, INC.242
TABLE 214MEDGYN PRODUCTS, INC.: BUSINESS OVERVIEW242
TABLE 215MEDGYN PRODUCTS, INC.: PRODUCT OFFERINGS242
12.2OTHER PLAYERS234
12.2.1DXNOW, INC.234
12.2.2NIDACON INTERNATIONAL AB235
12.2.3GYNOTEC B.V.235
12.2.4SAR HEALTHLINE PVT. LTD.236
12.2.5INVITROCARE INC.237
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13APPENDIX247
13.1DISCUSSION GUIDE247
13.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL251
13.3AVAILABLE CUSTOMIZATIONS253
13.4RELATED REPORTS254
13.5AUTHOR DETAILS255

お問合せフォーム